These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 18672953

  • 41. [What remains of anti-arrhythmia drugs?].
    Lévy S.
    Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1501-5. PubMed ID: 8010849
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Non-pharmacological treatment of ventricular tachycardia (anti-arrhythmic surgery excluded)].
    Touboul P.
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):809-17. PubMed ID: 8267510
    [Abstract] [Full Text] [Related]

  • 46. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 47. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A, Pieragnoli P, Ricciardi G, Giaccardi M, Padeletti L, Michelucci A.
    Minerva Cardioangiol; 2007 Jun 12; 55(3):341-51. PubMed ID: 17534253
    [Abstract] [Full Text] [Related]

  • 48. Circadian, daily, and seasonal distributions of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Anand K, Aryana A, Cloutier D, Hee T, Esterbrooks D, Mooss AN, Mohiuddin SM.
    Am J Cardiol; 2007 Oct 01; 100(7):1134-8. PubMed ID: 17884377
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T, Groysman R, Meilichov I.
    Pharmacotherapy; 2008 Jan 01; 28(1):14-9. PubMed ID: 18154469
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Risk assessment for defibrillator therapy: Il Trittico.
    Anderson KP.
    J Am Coll Cardiol; 2007 Sep 18; 50(12):1158-60. PubMed ID: 17868807
    [No Abstract] [Full Text] [Related]

  • 57. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
    Borleffs CJ, van Erven L, Schotman M, Boersma E, Kiès P, van der Burg AE, Zeppenfeld K, Bootsma M, van der Wall EE, Bax JJ, Schalij MJ.
    Eur Heart J; 2009 Jul 18; 30(13):1621-6. PubMed ID: 19493865
    [Abstract] [Full Text] [Related]

  • 58. [Therapeutic strategies in inappropriate ICD therapy].
    Klein G, Korte T.
    Herz; 2005 Nov 18; 30(7):619-24. PubMed ID: 16333588
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.